MARINELLI, SARA
 Distribuzione geografica
Continente #
AS - Asia 2.823
NA - Nord America 1.547
EU - Europa 861
SA - Sud America 510
AF - Africa 45
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.790
Nazione #
US - Stati Uniti d'America 1.461
SG - Singapore 1.128
CN - Cina 699
BR - Brasile 402
IT - Italia 307
VN - Vietnam 287
HK - Hong Kong 268
FR - Francia 159
KR - Corea 158
DE - Germania 77
JP - Giappone 75
NL - Olanda 68
FI - Finlandia 66
GB - Regno Unito 52
IN - India 51
CA - Canada 47
BD - Bangladesh 42
AR - Argentina 39
MX - Messico 24
IL - Israele 21
EC - Ecuador 18
AT - Austria 17
ZA - Sudafrica 17
ID - Indonesia 16
PL - Polonia 16
IE - Irlanda 15
RU - Federazione Russa 14
TR - Turchia 14
VE - Venezuela 13
ES - Italia 12
IQ - Iraq 10
KE - Kenya 10
PE - Perù 10
CL - Cile 9
CO - Colombia 9
SE - Svezia 9
PY - Paraguay 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
PH - Filippine 6
UA - Ucraina 6
EE - Estonia 5
MA - Marocco 5
PK - Pakistan 5
DZ - Algeria 4
EG - Egitto 4
KZ - Kazakistan 4
LV - Lettonia 4
MY - Malesia 4
RS - Serbia 4
AL - Albania 3
JM - Giamaica 3
JO - Giordania 3
LB - Libano 3
LT - Lituania 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
BS - Bahamas 2
BY - Bielorussia 2
CH - Svizzera 2
LK - Sri Lanka 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
AU - Australia 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
BO - Bolivia 1
CR - Costa Rica 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
SI - Slovenia 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.790
Città #
Singapore 658
Santa Clara 460
Hefei 333
Hong Kong 266
San Jose 179
Seoul 156
Ashburn 128
Lauterbourg 124
Rome 118
Beijing 117
Dallas 114
Ho Chi Minh City 112
Los Angeles 76
Hanoi 68
Tokyo 50
Helsinki 36
São Paulo 36
Frankfurt am Main 29
New York 28
Milan 25
Buffalo 21
Turku 21
Minamishinagawa 19
Montreal 19
Orem 18
Amsterdam 17
Nuremberg 16
London 15
Warsaw 15
Atlanta 14
Vienna 14
Bengaluru 13
Dublin 13
Haiphong 13
Belo Horizonte 11
Brooklyn 11
Chicago 11
Rio de Janeiro 11
Biên Hòa 10
Chennai 10
Johannesburg 10
Naples 10
Council Bluffs 9
Curitiba 9
Denver 9
Lappeenranta 9
Mexico City 9
Nairobi 9
Poplar 9
Toronto 9
Da Nang 8
Falkenstein 8
Munich 8
Dhaka 7
Düsseldorf 7
Lima 7
Shanghai 7
Stockholm 7
Tashkent 7
Ankara 6
Boston 6
Fortaleza 6
Guayaquil 6
Hải Dương 6
Paris 6
Phoenix 6
Porto Alegre 6
Portsmouth 6
Prague 6
Boardman 5
Campinas 5
Canoas 5
Nha Trang 5
Rae Parish 5
Bologna 4
Goiânia 4
Guangzhou 4
Guarulhos 4
Houston 4
Kyiv 4
Madrid 4
Osaka 4
Palombara Sabina 4
Recife 4
Ribeirão Preto 4
Riga 4
Salvador 4
Sorocaba 4
Thái Bình 4
Amman 3
Barquisimeto 3
Belgrade 3
Betim 3
Cairo 3
Caracas 3
Changsha 3
City of London 3
Corridonia 3
Cotia 3
Delhi 3
Totale 3.741
Nome #
Inhalation of nanoplastics in the mouse model: tissue biodistribution and effects on the olfactory system 136
Inhalation of nanoplastics in the mouse model: Tissue bio-distribution and effects on the olfactory system 115
Sex-specific adipose tissue's dynamic role in metabolic and inflammatory response following peripheral nerve injury 108
SNAP25 CLEAVAGE BY BOTULINUM NEUROTOXIN-A REPROGRAMS SCHWANN CELLS INTO A PROREGENERATIVE PHENOTYPE 107
Essential role of p21Waf1/Cip1 in the modulation of post-traumatic hippocampal Neural Stem Cells response 105
Impact of caloric restriction on peripheral nerve injury-induced neuropathic pain during ageing in mice 103
Role of Running-Activated Neural Stem Cells in the Anatomical and Functional Recovery after Traumatic Brain Injury in p21 Knock-Out Mice 98
Pharmacological Interaction of Botulinum Neurotoxins with Excitatory and Inhibitory Neurotransmitter Systems Involved in the Modulation of Inflammatory Pain 98
Effects of age-related loss of P/Q-type calcium channels in a mice model of peripheral nerve injury 93
Nuovo uso della tossina botulinica per il recupero da paralisi dopo lesione del midollo spinale 90
BoNT-A as a Possible Treatment fo Chronic Spinal Cord Injury 85
Botulinum Toxin B Affects Neuropathic Pain but Not Functional Recovery after Peripheral Nerve Injury in a Mouse Model 84
Pain-related behaviours in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 82
Modeling socially anhedonic syndromes: genetic and pharmacological manipulation of opioid neurotransmission in mice 79
The Rac GTPase-activating bacterial protein toxin CNF1 induces analgesia up-regulating mu-opioid receptors 77
Inhalation of nanoplastics in the mouse model: tissue bio-distribution and effects on the olfactory system 76
null 75
100x100CNR. Incontri mattutini a IBBC con 100 studenti liceali del territorio 75
Give a selfie for women @CNR 73
300x100: Protagoniste per la ricerca 71
Sex Differences in Neuropathy: The Paradigmatic Case of MetFormin 70
Xeomin((R)), a Commercial Formulation of Botulinum Neurotoxin Type A, Promotes Regeneration in a Preclinical Model of Spinal Cord Injury 70
Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice 69
Altered pain sensitivity in mice lacking the CaV2.1alpha1 subunit of P/Q-type Ca2+ channels 68
CXCR2 increases in ALS cortical neurons and its inhibition prevents motor neurons degeneration in vitro and improves neuromuscular function in SOD1G93A mice 68
Revealing the Therapeutic Potential of Botulinum Neurotoxin Type A in Counteracting Paralysis and Neuropathic Pain in Spinally Injured Mice 66
Sexually dimorphic immune and neuroimmune changes following peripheral nerve injury in mice: novel insights for gender medicine 64
Innovative mouse model mimicking human-like features of spinal cord injury: efficacy of Docosahexaenoic acid on acute and chronic phases 64
The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord 63
Effects of caloric restriction on neuropathic pain, peripheral nerve degeneration and inflammation in normometabolic and autophagy defective prediabetic Ambra1 mice 62
Botulinum neurotoxins and formalin-induced pain: central vs. peripheral effects in mice. 60
Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain 60
Nutrition and Neurological Disorders 1st Edition 60
EFFECTS OF BOTULINUM NEUROTOXIN TYPE B IN NEUROPATHIC MICE: BEHAVIORAL AND IMMUNOHISTOCHEMICAL INVESTIGATIONS 60
Nuova applicazione terapeutica della neurotossina botulinica sierotipo A 59
Central injection of botulinum neurotoxins: behavioural effects in mice. 58
The role of glial cells in the experience of pain: how much is important the sex factor? 58
Sex differences and modulatory effect of 17beta-estradiol on behavioral and immune responses in neuropathic mice. 54
Wheel Running Adversely Affects Disease Onset and Neuromuscular Interplay in Amyotrophic Lateral Sclerosis Slow Progression Mouse Model 54
METHOD FOR THE POTENTIATION OF OPIOID ANALGESICS EFFECTS ON PAIN 53
D-aspartate modulates nociceptive-specific neuron activity and pain threshold in inflammatory and neuropathic pain condition in mice 53
From the Gender Gap to Neuroactive Steroids: Exploring Multiple Cases to Further Understand Neuropathic Pain 53
Przeciwbólowe efekty toksyny botulinowej A w szczurzym modelu bólu neuropatycznego. 53
Setting-up a multimodal and integrated sensory platform to analyze the impact of two mouse models (C57BL6/N; CD-1) in aging research 53
A Step Forward: About the Progresses Made in the Second Edition of the Special Issue "The Multiple Mechanisms Underlying Neuropathic Pain" 52
The influence of BoNT/A administration on IL-1 family members in rat neuropathic pain model - in vivo and in vitro evidences. 52
Effects of caloric restriction on neuropathic pain, peripheral nerve degeneration and inflammation in normometabolic and autophagy defective prediabetic Ambra1 mice 52
17beta-estradiol counteracts neuropathic pain: a behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice. 51
In vitro receptor binding properties of a painless NGF mutein, linked to Hereditary Sensory Autonomic Neuropathy type V 50
Intranasal "painless" human Nerve Growth Factors slows amyloid neurodegeneration and prevents memory deficits in App X PS1 mice 50
Schwann cell autophagy counteracts the onset and chronification of neuropathic pain 49
A new clinical relevant murine model of spinal cord injury mimicking the pathological features of complete paralysis in humans. 48
Activation of skeletal muscle-resident glial cells upon nerve injury 48
Higher pain perception and lack of recovery from neuropathic pain in females: A behavioural, immunohistochemical, and proteomic investigation on sex-related differences in mice 48
Rac-dependent pathway and cytoskeleton remodeling: a newintracellular mechanism for modulation of inflammatory pain 47
Botulinum neurotoxin type A counteracts neuropathic pain and facilitates functional recovery after peripheral nerve injury in animal models. 46
Endocannabinoid signaling in microglia 46
CNF1 BACTERIAL TOXIN PROTEIN FROM E. COLI AS ANALGESIC 45
Long term effect of neonatal inflammatory on pain sensitivity and social behaviour in mice 43
Altered sensitivity to nociceptive stimuli in mice lacking the CaV2.1 alpha1 subunit of P/Q-type Ca2+ channels. 41
Remission of hair loss and induction of hair regrowth by botulinum neurotoxin A in mice 40
Pain sensitivity in mice lacking the Ca(v)2.1alpha1 subunit of P/Q-type Ca2+ channels. 40
Botulinum toxin A increases analgesic effects of morphine, counters development of morphine tolerance and modulates glia activation and ? opioid receptor expression in neuropathic mice. 40
Correction to: Denervation-activated STAT3–IL-6 signalling in fibro-adipogenic progenitors promotes myofibres atrophy and fibrosis 40
Endocannabinoid signaling in microglia 39
TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice 39
Role of Schwann cell autophagy in an animal model of neuropathic pain: functional and structural investigations 38
ProNGF\NGF imbalance triggers learning and memory deficits, neurodegeneration and spontaneous epileptic-like discharges in transgenic mice. 38
Caloric restriction as a nutrition strategy in counteracting peripheral neuropathies ( Book Chapter) Diet and Nutrition in Neurological Disorders 38
Botulinum neurotoxin serotype A: an innovative pharmacological approach for pain treatment. 36
The Analgesic Effect on Neuropathic Pain of Retrogradely Transported botulinum Neurotoxin A Involves Schwann Cells and Astrocytes 36
Is the retrograde transport of botulinum neurotoxin type A involved in its analgesic effects on neuropathic pain? 35
Botulinum neurotoxin serotype A improves behavioural responses and peripheral nerve regeneration in a mouse model of neuropathic pain 34
Altered sensitivity to nociception stimuli in mice lacking the CaV2.1alpha1 subunit of PQ-type Ca2+ channels 32
Taking Pain Out of NGF: A "Painless" NGF Mutant, Linked to Hereditary Sensory Autonomic Neuropathy Type V, with Full Neurotrophic Activity 31
Botulinum neurotoxin serotype A and morphine: a successful pharmacological combination for treating inflammatory pain 30
Behavioral and immunohistochemical sex-related differences in neuropathic mice. 30
Single cycle structure-based humanization of an anti-nerve growth factor therapeutic antibody 30
The effect of botulinum neurotoxin A on CCI-Induced neuroimmunological chnages in DRG and spinal cord 28
The function neutralizing anti-TrkA antibody MNAC13 reduces inflammatory and neuropathic pain. 28
Analgesic effects of the bacterial protein toxin CNF1 in inflammatory pain. 27
Morphine and botulinum neurotoxin A: a successful pharmacological combination against pain? 27
Editorial: Neuroinflammation and Neuroautoimmunity in Peripheral Neuropathies: Old Players, New Roles 26
Botulinum neurotoxins: new frontiers in neuropathic pain therapy? 26
The bacterial protein toxin CNF1 induces analgesic effects and upregulates mu opioid receptors in a model of neuropathic pain 26
M2 receptors exert analgesic action on DRG sensory neurons by negatively modulating VR1 activity 26
Alterations of neuroexocytosis induced by botulinum neurotoxins: behavioural effects in mice 26
Altered pain sensitivity in mice lacking the CaV2.1?1 subunit of P/Q-type Ca2+ channels. 25
Treadmill exercise counteracts neuropathic pain, reduces spinal glial cells expression and enhances regeneration after sciatic nerve injury 25
The bacterial protein toxin CNF1 induces analgesic effects and upregulates mu opioid receptors in a model of neuropathic pain 24
Repeated voluntary exercise induces impairments and disease worsening in the low-copy SOD1G93A mouse model of ALS 24
A humanized anti-NGF antibody with analgesic properties 24
Anti-allodynic efficacy of Botulinum neurotoxin A in a model of neurophatic pain 24
Short-lasting but not long-lasting treadmill exercise counteracts neuropathic pain and accelerates functional recovery in mice 24
Central and peripheral effects of botulinum neurotoxins on formalin pain 23
Comparison between short- and long-lasting treadmill exercise: effects on mechanical allodynia and functional recovery after sciatic nerve injury 23
Central and peripheral effects of botulinum neurotoxins on formalin pain. 23
Targeting cancer stem cells in medulloblastoma by inhibiting AMBRA1 dual function in autophagy and STAT3 signalling 23
Inhibition of glial activation by minocycline modifies the effects of botulinum neurotoxin in a model of neuropathic pain. 23
Central injection of botulinum neurotoxins modulates formalin induced inflammatory pain in mice 22
Totale 5.243
Categoria #
all - tutte 17.263
article - articoli 9.974
book - libri 148
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 140
Totale 27.525


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202468 0 0 0 0 0 0 0 0 9 5 38 16
2024/20252.072 8 6 144 83 422 119 42 151 65 84 515 433
2025/20263.737 214 479 445 585 618 192 502 150 180 263 109 0
Totale 5.877